US 11844769
Use of cysteamine and derivatives thereof to suppress tumor metastases
granted A61KA61K31/145A61K45/06
Quick answer
US patent 11844769 (Use of cysteamine and derivatives thereof to suppress tumor metastases) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/145, A61K45/06, A61K9/0053, A61K9/28